Stem Cell Therapies Considered Interchangeable Contain Different Cell Types UC San Diego's transcriptional and proteomic atlas revealed that BMAC and ADSVF populations had very different cell type compositions
Genetic Engineering & Biotechnology News
Book and Periodical Publishing
New Rochelle, New York 178,200 followers
The Bedrock of Biotech
About us
Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Celebrating its 40th anniversary in 2021, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new tools and technologies, investment growth, and career opportunities. Through its cornerstone Magazine, dynamic Website, high-frequency eNewsletters, and innovative suite of multimedia, GEN is the 360-degree resource that researchers and executives depend on for information that is pivotal for their success. GEN’s breadth of editorial coverage is unrivaled, providing exclusive reporting, insight, and analysis across the life sciences – from its five foundational pillars of Drug Discovery, Bioprocessing, OMICS, Translational Medicine, and Gene Editing to a new, expanded focus on the emerging areas of Cancer Research, Infectious Diseases, and Artificial Intelligence. Within these areas, GEN delivers exclusive, high-quality reporting on the latest industry news; insider information on cutting-edge tools and technologies; industry-standard protocols, tutorials, and technical articles; first-looks at emerging industry collaborations and investments; reports from key scientific and industry meetings; and A-Lists, our monthly insight and analysis into the top companies, products, and movers & shakers impacting the industry today.
- Website
-
http://www.genengnews.com
External link for Genetic Engineering & Biotechnology News
- Industry
- Book and Periodical Publishing
- Company size
- 51-200 employees
- Headquarters
- New Rochelle, New York
- Type
- Privately Held
- Founded
- 1981
- Specialties
- Biotechnology, Drug Discovery, Bioprocessing, Translational Medicine, OMICS, and Genome Editing
Locations
-
Primary
140 Huguenot St
New Rochelle, New York 10801, US
Employees at Genetic Engineering & Biotechnology News
Updates
-
Replacing Chemo: Vertex, Orum Launch Up to $945M+ DAC Collaboration Casgevy co-developer, Vertex Pharmaceuticals and Boston biotech Orum Therapeutics are partnering to discover degrader antibody conjugates as targeted conditioning agents for use with gene editing therapies.
Replacing Chemo: Vertex, Orum Launch Up to $945M+ DAC Collaboration
genengnews.com
-
Parkinson’s Disease Aggregates Do Not Appear to Evolve from Protein Droplets The deeper understanding of the complex interplay between protein aggregation and liquid-liquid phase separation is relevant not only for Parkinson’s, but also other neuro-degenerative diseases characterized by protein aggregation, including Alzheimer’s, Huntingdon’s, and Creutzfeldt-Jakob disease. In turn, this could lead to new treatments.
Parkinson’s Disease Aggregates Do Not Appear to Evolve from Protein Droplets
genengnews.com
-
Zoonotic Web Unravels Complexity of Transmission Chains Taking a deep dive into the eco-epidemiology of zoonotic events, researchers have dissected the complex interactions involved in zoonoses with the concept of a "zoonotic web"--a detailed network representation of the relationships between zoonotic agents, their hosts, vectors, food sources, and the environment. Using this approach, new findings Vetmeduni and Complexity Science Hub show that, in Austria, zoonotic spillover is most likely to occur at human-cattle and human-food interfaces.
Zoonotic Web Unravels Complexity of Transmission Chains
genengnews.com
-
Novel Gut Therapy May Potentially Be Used to Protect against Adult-Onset Asthma During the first years of life, a stable gut microbiota is shaped by food intake as well as genetics and environmental exposures. Working in mice predisposed to develop asthma, a research team from Monash University found that when given antibiotics in early life, the mice were more susceptible to house-dust mite-induced allergic airway inflammation, and this lasted into adulthood.
Novel Gut Therapy May Potentially Be Used to Protect against Adult-Onset Asthma
genengnews.com
-
LAST CHANCE! Endpoints: Considerations for Hit to Lead Selection of a Bispecific Antibody in Oncology In this GEN webinar TODAY, Chiu, Mark, PhD, will present a process for selecting an EGFR x cMET bispecific antibody to treat patients with EGFR inhibitor-resistant non-small lung cancer. Register now to join us for this free webinar sponsored by Cell Signaling Technology (CST): https://ow.ly/xZ5250SqsZi #Cancer #DrugDiscovery #TranslationalMedicine
-
-
Inflammation in Macrophages Found as a Driving Force in Rare Genetic Conditions Researchers at The Hospital for Sick Children (SickKids) have uncovered that inflammation in macrophages may be responsible in part for some severe symptoms in a group of rare genetic conditions called lysosomal storage diseases (LSDs).
Inflammation in Macrophages Found as a Driving Force in Rare Genetic Conditions
genengnews.com
-
Novel Gut Therapy May Potentially Be Used to Protect against Adult-Onset Asthma Early exposure to antibiotics can trigger long-term susceptibility to asthma, according to scientists from Monash University. However, the researchers have isolated a molecule produced by gut bacteria that in the future could potentially be trialed as a dietary supplement therapy for children at risk of asthma to prevent them developing the disease.
Novel Gut Therapy May Potentially Be Used to Protect against Adult-Onset Asthma
genengnews.com
-
Qubit Number to Simulate Molecules Reportedly Reduced by the Sorbonne Université and Qubit Pharmaceuticals Researchers have developed new algorithms that break down a quantum calculation into its various components.
Qubit Number to Simulate Molecules Reportedly Reduced by the Sorbonne and Qubit Pharmaceuticals
genengnews.com
-
Phages Can Weaponize Selfish Genetic Elements to Outcompete Peers Among phages, a selfish genetic element has been found to encode an intron endonuclease that facilitates interference competition. One phage can deploy the intron endonuclease to cut the DNA of a competing virus, disrupting its reproduction. Understanding such mechanisms could lead to better phage therapy cocktails. The study was conducted by UC San Diego researchers.
Phages Can Weaponize Selfish Genetic Elements to Outcompete Peers
genengnews.com